Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
NeoPep Vaccine1 / Hangzhou NeoVax Biotech
NCT05557240: Neoantigens Phase I Trial in Newly Diagnosed Glioblastoma Patients	Recruiting	1	10	RoW	NeoPep Vaccine1 plus Poly-ICLC, NPVAC1+Poly-ICLC, NeoPep Vaccine2 plus Poly-ICLC, NPVAC2+Poly-ICLC	Shanghai 10th People's Hospital, Hangzhou NeoVax Biotechnology Co. LTD	Glioma, Malignant, Antigen-specific Vaccines, Individualized Treatment	02/24	08/25
NeoPep Vaccine2 / Hangzhou NeoVax Biotech
No trials found